Universe Pharmaceuticals ... (UPC)

AI Score

Unlock

4.17

0.37 (9.74%)

At close: Apr 25, 2025, 3:59 PM

4.20

0.72%

Pre-market: Apr 28, 2025, 06:30 AM EDT

Universe Pharmaceuticals INC Income Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018
Period Ending	Mar 31, 2024	Sep 30, 2023	Mar 31, 2023	Sep 30, 2022	Mar 31, 2022	Sep 30, 2021	Mar 31, 2021	Sep 30, 2020	Mar 31, 2020	Sep 30, 2019	Mar 31, 2019	Sep 30, 2018	Mar 31, 2018
Revenue	12.88M	13.84M	18.47M	15.94M	24.2M	23.69M	24.29M	15.35M	15.35M	16.61M	8.31M	14.26M	7.13M
Cost of Revenue	9.64M	9.78M	12.45M	7.89M	10.57M	10.42M	12.42M	8.31M	8.31M	9.91M	4.96M	7.55M	3.78M
Gross Profit	3.24M	4.06M	6.01M	8.05M	13.63M	13.26M	11.87M	7.05M	7.05M	6.7M	3.35M	6.7M	3.35M
Operating Income	-1.74M	-3.68M	149.25K	-10.14M	2.7M	4.01M	9.58M	5.17M	5.17M	4.88M	2.44M	4.83M	2.41M
Interest Income	n/a	n/a	166.93K	n/a	696.43K	239.55K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-12.44M	-4.14M	258.93K	-11.33M	3.31M	4.12M	9.53M	5.05M	5.05M	4.83M	2.41M	4.76M	2.38M
Net Income	-13.1M	-5.45M	-715.43K	-10.47M	1.73M	4.17M	7.15M	3.78M	3.78M	3.78M	1.89M	3.8M	1.9M
Selling & General & Admin	4.85M	5.06M	3.55M	10.58M	10.72M	3.96M	1.91M	1.4M	1.4M	1.52M	759.05K	1.48M	740.8K
Research & Development	74.7K	2.57M	2.25M	7.49M	134.46K	5.15M	301.93K	291.56K	291.56K	309.22K	154.61K	394.69K	197.34K
Other Expenses	-57.6K	-110.59K	-68.6K	-128.34K	-77.24K	-147.38K	-76.6K	182.88K	182.88K	n/a	n/a	n/a	n/a
Operating Expenses	4.98M	7.74M	5.87M	18.19M	10.93M	9.26M	2.29M	1.87M	1.87M	1.83M	913.66K	1.88M	938.15K
Interest Expense	136.61K	82.22K	74.57K	74.01K	88.39K	54.93K	46.67K	61.88K	61.88K	64.63K	32.32K	82.46K	41.23K
Selling & Marketing Expenses	n/a	n/a	n/a	-20.25M	n/a	1.81M	n/a	777.77K	777.77K	789.41K	394.71K	840.13K	420.06K
Cost & Expenses	14.62M	17.52M	18.32M	26.08M	21.5M	19.68M	14.71M	10.18M	10.18M	11.74M	5.87M	9.43M	4.71M
Income Tax Expense	665.15K	1.34M	974.36K	-825.8K	1.58M	-52.22K	2.41M	1.27M	1.27M	1.05M	525.4K	957.56K	478.78K
Shares Outstanding (Basic)	3.65M	3.63M	3.62M	3.63M	3.63M	3.63M	3.63M	21M	21M	21M	21M	21M	21M
Shares Outstanding (Diluted)	3.65M	3.63M	3.62M	3.63M	3.63M	3.63M	3.63M	21M	21M	21M	21M	21M	21M
EPS (Basic)	-3.59	-1.5	-0.2	-2.89	0.48	1.15	1.97	0.18	0.18	0.18	0.09	0.18	0.09
EPS (Diluted)	-3.59	-1.5	-0.2	-2.89	0.48	1.15	1.97	0.18	0.18	0.18	0.09	0.18	0.09
EBITDA	-12.05M	-3.81M	591.28K	-11.02M	3.69M	4.38M	9.82M	5.32M	5.32M	5.1M	2.55M	5.07M	2.53M
EBIT	-12.3M	-4.06M	333.5K	-11.26M	3.4M	4.17M	9.57M	5.11M	5.11M	4.89M	2.45M	4.84M	2.42M
Depreciation & Amortization	248.86K	251K	257.78K	241.84K	292.11K	203.41K	243.47K	205.04K	205.04K	209.21K	104.61K	226.37K	113.18K